# 39946-I Laser and Bevacizumab Treatment for Retinopathy of Prematurity

> **NCT01993043** · — · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 150 (actual)

## Conditions studied

- ROP Threshold

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01993043
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2020-10
- **Final completion:** 2023-09-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01993043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01993043, "39946-I Laser and Bevacizumab Treatment for Retinopathy of Prematurity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01993043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*